ACC 2018

Latest ACC 2018 News

Low Dose Rivaroxaban Plus Aspirin Reduces Major Adverse Limb Events in COMPASS

According to a new subgroup analysis of the COMPASS trial published in…

Sudarshana Datta, M.D.

SWAP 4 trial: De-escalation of P2Y12 Inhibitors

In a recent article published in The Circulation, it has been found…

Aditya Ganti, M.D.

HeartMate 3: Magnetic Pump in Advanced Heart Failure

According to a new study published in the New England Journal of…

Sudarshana Datta, M.D.

VEST: Wearable cardiac defibrillator decreases mortality post MI

The first randomized trial of the Wearable Cardiac Defibrillator (WCD) was conducted…

Sudarshana Datta, M.D.

Febuxostat Non-Inferior to Allopurinol in Reduction of MACE but Increases Mortality

In a recent article, published in The New England Journal of Medicine,…

Aditya Ganti, M.D.

ACC 2018 Wrap Up in Turkish

Dr. Kalayci and Dr. Kozan Discuss Subscribe on iTunes or Google Play.

Sadaf Sharfaei, M.D.

POISE: 1-Year Outcomes of Perioperative Beta-blockade in Noncardiac Surgery

Dr. Devereaux and Dr. Daaboul Discuss Subscribe on iTunes or Google Play.

Sadaf Sharfaei, M.D.

TRIUMPH: Low-dose Triple-Combination BP Lowering Pill for Initial Treatment of Hypertension

Dr. Webster and Dr. Gibson Discuss Subscribe on iTunes or Google Play.

Sadaf Sharfaei, M.D.

Cavitation Phenomenon Damages the Endothelium and Starts the Atherosclerotic Process

Dr. Nguyen and Dr. Daaboul Discuss Subscribe on iTunes or Google Play.

Sadaf Sharfaei, M.D.

Blood Pressure Reduction in Black Barbershops

Dr. Blyler and Dr. Daaboul Discuss Subscribe on iTunes or Google Play.

Sadaf Sharfaei, M.D.

PHARMACLO: A Pharmacogenomic Approach to Selecting Antiplatelet Therapy in Acute Coronary Syndrome

Dr. Ardissino and Dr. Gibson Discuss Subscribe on iTunes or Google Play.

Sadaf Sharfaei, M.D.

MOMENTUM III: HeartMate III demonstrated 2-year Survival Benefit Compared to HeartMate II

Dr. Mehra and Dr. Gibson Discuss Subscribe on iTunes or Google Play.

Sadaf Sharfaei, M.D.

CANTOS subanalysis: Effect of Canakinumab on New Onset Diabetes in Pre-Diabetic Patients

Dr. Everett and Dr. Gibson Discuss Subscribe on iTunes or Google Play.

Sadaf Sharfaei, M.D.